Elsevier

Brain Research

Volume 946, Issue 1, 9 August 2002, Pages 139-147
Brain Research

Research report
Different effects of eNOS and nNOS inhibition on transient forebrain ischemia

https://doi.org/10.1016/S0006-8993(02)02870-6Get rights and content

Abstract

To clarify the functions of nitric oxide (NO) induced by either neuronal NO synthase (nNOS) or endothelial NO synthase (eNOS) after transient cerebral ischemia, we investigated the effects of l-N5-(1-iminoethyl)ornithine (l-NIO), a relatively selective eNOS inhibitor, and 7-nitroindazole (7-NI), a relatively selective nNOS inhibitor, on hippocampal dysfunction caused by cerebral ischemia. We measured mean arterial blood pressure (MABP), hippocampal blood flow, direct current (DC) potential, CA1 population spike (PS) and extracellular concentrations of glutamate from rat hippocampus after transient forebrain ischemia, which was induced by four-vessel occlusion for 10 min. l-NIO (20 mg/kg) and 7-NI (25 mg/kg) were administered intraperitoneally 20 min before ischemia. l-NIO, but not 7-NI, increased MABP before, during and after ischemia, compared with the vehicle group. 7-NI, but not l-NIO, reduced the amplitude of anoxic depolarization induced by ischemia. 7-NI recovered the PS amplitude in part 60 min after ischemia. 7-NI, but not l-NIO, reduced the ischemia-induced levels of glutamate. These results indicate that nNOS inhibition with 7-NI improves, at least in part, hippocampal dysfunction after ischemia, while eNOS inhibition with l-NIO worsens it.

Introduction

Nitric oxide (NO) is produced endogenously by the conversion of l-arginine to citrulline by NO synthase (NOS). NO is synthesized by three different types of NOS including the constitutive calcium/calmodulin-dependent neuronal and endothelial isoforms and the inducible calcium-independent isoform [14], [35]. NO plays an important role in the modulation of vascular tone and neurotransmission [23]. Moreover, there is increasing evidence that NO produced both during and after cerebral ischemia may be an important factor in the pathogenesis of neuronal ischemic injury [14], [16]. During the early stages of cerebral ischemia, endothelial NOS (eNOS) and neuronal NOS (nNOS) are continuously active and produce large amounts of NO [14], [43], [44]. eNOS-derived NO is beneficial in promoting collateral circulation and microvascular flow [14]. In contrast, nNOS-derived NO is detrimental in the early stages of transient cerebral ischemia [8], [30].

It is well known that cerebral ischemia induces a massive increase in glutamate release (for recent review, see Ref. [28]). At the same time, glutamate-induced Ca2+ overload in ischemic neurons leads to a persistent activation of nNOS, resulting in continuous NO production [14], [35]. The overproduction of nNOS-derived NO leads to neurotoxicity [10], [35]. The neurotoxic actions of NO are mediated by peroxynitrite, the reaction product of NO and superoxide anion [4].

In global forebrain ischemia, the amount of glutamate released in rats treated with NG-nitro-l-arginine methyl ester hydrochloride (l-NAME), a non-specific NOS inhibitor, has been reported to increase [17], [42], decrease [32] or not change [46]. One reason for the discrepancy may be related to the lack of specificity of the inhibitor (l-NAME): l-NAME not only inhibits nNOS in brain but also causes a sustained increase in blood pressure by inhibiting eNOS.

l-N5-(1-iminoethyl)ornithine (l-NIO) is a relatively selective inhibitor of eNOS [26], [39]. l-NIO reduces resting cyclic GMP levels and constricts pial arteries, both consistent with the idea that eNOS contributes to resting vascular tone [23]. On the other hand, 7-nitroindazole (7-NI) is relatively selective for the neuronal isoform of NOS [25]. 7-NI has no significant effects on mean arterial blood pressure (MABP) [3], [37] and cerebral blood flow [1], [15]. Yoshida et al. [40] showed that 7-NI had no effect on MABP or on the response to acetylcholine, suggesting no eNOS activity in vivo. It has been reported that 7-NI decreases focal infarct volume [40] and provides protection against ischemia-induced cell death in the CA1 region of the gerbil hippocampus [29]. Kahn et al. [18] have recently found that 7-NI reduces the glutamate levels in the striatum during ischemia and reperfusion.

Our previous study showed that 7-NI markedly inhibits NO production in the rat hippocampus during post-ischemic early reperfusion [15]. At present, we do not know the effects of relatively selective eNOS inhibitors on hippocampal neuronal dysfunction after transient forebrain ischemia. In the present study, therefore, to better understand the differential roles of eNOS- and nNOS-derived NO, we investigated the effects of 7-NI and l-NIO, which have differential inhibitory actions on eNOS and nNOS, on transient forebrain ischemia using electrophysiological and microdialysis methods.

Section snippets

Animal preparation

All procedures followed our previous studies [15], [19] with some modifications. The present study was carried out according to ‘The Guiding Principles for Care and Use of Animals in the Field of Physiological Sciences’ (The Physiological Society of Japan). Adult male Wistar rats weighing between 280 and 320 g were used. On the day before the experiment, the rats were anesthetized with pentobarbital sodium (40 mg/kg, i.p.) and the bilateral vertebral arteries were electrocauterized. On the

Physiological variables

The arterial Pao2, Paco2 and pH values were measured at the end of each experiment. However, they did not show any significant differences among groups (data not shown).

Effects of 7-NI and l-NIO on hippocampal blood flow and MABP

Fig. 2 shows representative records of MABP, hippocampal blood flow and DC potential activity before, during and after transient forebrain ischemia in the vehicle, 7-NI and l-NIO groups. Both 7-NI and l-NIO did not affect the hippocampal blood flow values 20 min after drug administration, 10 min after the onset of ischemia and

Discussion

In the present study, we have observed for the first time the effects of l-NIO on the hippocampal CA1 PS amplitudes and levels of glutamate during transient global ischemia. The main findings were as follows: (1) l-NIO, but not 7-NI, increased MABP before, during and after ischemia; (2) 7-NI, but not l-NIO, reduced the AD amplitudes during ischemia and partially recovered the PS amplitudes 60 min after the onset of reperfusion, compared with the vehicle group; (3) 7-NI, but not l-NIO, reduced

Acknowledgements

We thank Dr Iso, Department of Behavior, Hyogo College of Medicine, for the statistical analysis. This work was supported in part by Hyogo College of Medicine Research Grant for M.-H. Jiang.

References (46)

  • J.W. Phillis et al.

    Characterization of glutamate, aspartate, and GABA release from ischemic rat cerebral cortex

    Brain Res. Bull.

    (1994)
  • D.J. Wolff et al.

    Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-l-lysine and N5-iminoethyl-l-ornithine

    Eur. J. Pharmacol.

    (1998)
  • Y. Zagvazdin et al.

    Evidence from its cardiovascular effects that 7-nitroindazole may inhibit endothelial nitric oxide synthase in vivo

    Eur. J. Pharmacol.

    (1996)
  • M. Chalimoniuk et al.

    NMDA receptor-dependent nitric oxide and cGMP synthesis in brain hemispheres and cerebellum during reperfusion after transient forebrain ischemia in gerbils: effect of 7-nitroindazole

    J. Neurosci. Res.

    (1998)
  • N. Cholet et al.

    Local uncoupling of the cerebrovascular and metabolic responses to somatosensory stimulation after neuronal nitric oxide synthase inhibition

    J. Cereb. Blood Flow Metab.

    (1997)
  • B.J. DeWitt et al.

    Differential effects of l-N5-(1-iminoethyl)-ornithine on tone and endothelium-dependent vasodilator responses

    Am. J. Physiol.

    (1997)
  • J.L. Dinerman et al.

    Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: Implications for synaptic plasticity

    Proc. Natl. Acad. Sci. USA

    (1994)
  • K.J. Escott et al.

    Cerebroprotective effect of the nitric oxide synthase inhibitors, 1-(2-trifluoromethylphenyl) imidazole and 7-nitro indazole, after transient focal cerebral ischemia in the rat

    J. Cereb. Blood Flow Metab.

    (1998)
  • A.K.M. Hammarstrom et al.

    Nitric oxide increases persistent sodium current in rat hippocampal neurons

    J. Physiol.

    (1999)
  • A. Hobbs et al.

    Inhibition of nitric oxide synthase as potential therapeutic target

    Annu. Rev. Pharmacol. Toxicol.

    (1999)
  • Z. Huang et al.

    Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-l-arginine

    J. Cereb. Blood Flow Metab.

    (1996)
  • Z. Huang et al.

    Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase

    Science

    (1994)
  • A. Kader et al.

    Nitric oxide production during focal cerebral ischemia in rats

    Stroke

    (1993)
  • Cited by (73)

    • ACE2/angiotensin-(1–7)/mas receptor axis in the central nervous system

      2023, Angiotensin: From the Kidney to Coronavirus
    • Role of neuronal nitric oxide synthase on cardiovascular functions in physiological and pathophysiological states

      2020, Nitric Oxide - Biology and Chemistry
      Citation Excerpt :

      Although caustic, this inflammatory phenomenon does not occur in neurons that possess nNOS possibly due to proximity interactions with phosphofructokinase (PFK1), which would protect the neurons through regulation of glycolysis. It has been shown that nNOS expression increases with CVA, and also causes changes in the homeostatic regulation of heart rate, blood pressure, myocardial contractility, and the autonomic nervous system (ANS); both physiologically and during times of stress/activity/exercise [68–71]. In summary, we have briefly described the structure, domain, location, motif, receptors involved, and regulation of nNOS, and its relationship with certain cardiovascular activities.

    View all citing articles on Scopus
    View full text